← FDA Drug Approvals (Drugs@FDA)

INVELTYS

NDA · New Drug Application · Sponsor: ALCON LABS INC · Approved 2018-08-22

Drug application

FDA Application #

NDA210565

Application type

New Drug Application

Brand name

INVELTYS

Generic name

LOTEPREDNOL ETABONATE

Active ingredients

LOTEPREDNOL ETABONATE

Dosage form

SUSPENSION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

ALCON LABS INC

Manufacturer

ALCON LABORATORIES, INC.

First approval

2018-08-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown